Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.
about
Molecular advances in the cell biology of SARS-CoV and current disease prevention strategiesSevere acute respiratory syndrome coronavirus 7a accessory protein is a viral structural proteinCoronavirus virulence genes with main focus on SARS-CoV envelope geneCharacterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane ProteinChimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.Discrimination of influenza A subtype by antibodies recognizing host-specific amino acids in the viral nucleoprotein.The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles.Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice.SARS-CoV envelope protein palmitoylation or nucleocapid association is not required for promoting virus-like particle productionA single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike proteinSelf-assembly of severe acute respiratory syndrome coronavirus membrane protein.Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein.A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein.The coronavirus nucleocapsid is a multifunctional protein.The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells.HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virionsVaccines: past, present and future.Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein.Incorporation of spike and membrane glycoproteins into coronavirus virions.A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.Exceptional flexibility in the sequence requirements for coronavirus small envelope protein functionThe ns12.9 Accessory Protein of Human Coronavirus OC43 Is a Viroporin Involved in Virion Morphogenesis and Pathogenesis.Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoproteinEnvelope protein palmitoylations are crucial for murine coronavirus assembly.Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoVHosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.More than one door - Budding of enveloped viruses through cellular membranes.Identifying SARS-CoV membrane protein amino acid residues linked to virus-like particle assembly.SARS coronavirus accessory proteins.A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.The coronavirus E protein: assembly and beyond.The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent MechanismPersistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein.The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles.Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein.The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.
P2860
Q21245141-337E49C9-1789-4A93-9161-BD355BBAB5D0Q24674321-41271950-FC55-4158-902F-F1DAD9BA75FCQ26827561-5332C19A-EC69-4487-813F-5FB5FD5357B7Q28354737-FA5AA4E4-39FC-41AB-84DD-CECCBA6821C1Q30404941-EAC0C0ED-FBBC-40E6-AC07-43CBEC2BDC0BQ30413011-4388B2B5-2B8D-4031-8FD6-2D7AF2D575F0Q30484261-2D1A976E-AAA1-444F-AB62-42D5C959018BQ30833219-AFB37050-BBEF-49BE-94B1-70373C4F414BQ33582305-F38109F3-5AFB-4E5F-BC2B-1BD7A01F84C6Q33614610-63783E72-1E3D-4F59-8A46-5D1F6B4C9727Q33800043-7F83E071-4C84-4655-9AB1-5984016D5CA3Q34037293-5B80380E-802F-4047-A8E3-4ECD360DD9C8Q34092794-90E84D41-F210-4096-B608-453D276C6245Q34102257-5760F006-29E0-4715-8338-D7D3862444A5Q34158687-69526E1D-611C-43B2-8963-3220CD9FA82AQ34233067-B62579D2-A3A2-43CE-BD1D-FA09108A83D9Q34389347-FF26AFBA-56F1-4F3F-A7A1-CF98EC1869B2Q34409178-BD48B73C-AE62-47B2-8757-639D778A1501Q35076542-81BE35DA-4F36-49AD-9958-11DD372BAADDQ35076973-08673587-45AA-410D-9CF5-E09C809488F3Q35544383-BE9AB911-7612-48F6-913F-8683661A81CFQ35635337-13FBF295-0E60-46B8-A4D4-B6574ACCA53AQ35784645-57EB9495-4B25-4308-ACE3-60982738610CQ35784722-626C652C-86BF-434E-BE3A-A659EA92D944Q36281808-C2AFCF63-09D1-4B0C-B6A7-CB25A21835DEQ36315168-90D23997-8412-40EF-9E7E-5D655F8E621CQ36484042-746639A7-129A-4B7C-82AE-724D1C576421Q36496355-17F0596B-284E-4471-8C9A-C6FBD9303C19Q36520754-C7EB0345-DE23-4F7F-994F-0AD3783FAC1FQ36784740-1F5EF44A-385A-4261-80C5-B8C613A4E7E8Q36791778-0E8A0797-92E7-4B68-A7D8-C17894A260E9Q36859360-49A921AF-B738-48BA-B493-F9607F098741Q37018286-4DC9E095-1D90-47DD-89A3-CECAE4CAFD26Q37033726-D6FBA04F-A8DA-466D-BC14-2B5974D33AB8Q38010442-EB8D7AC7-048F-497B-B787-1A411B0B7718Q38404223-4F4BD425-F062-4786-A1BD-25DC912315D0Q38610308-1C71C3BE-736B-49D9-958B-50CBFB6D36A2Q38773205-76AB8340-67EC-4673-BCB2-0A506F3EF128Q39836815-883DF703-CD9D-41CF-B280-32C1293194FBQ40213197-90387A9D-5137-4A76-AA61-03B9C7628F90
P2860
Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Generation of synthetic severe ...... sembly and vaccine production.
@en
Generation of synthetic severe ...... sembly and vaccine production.
@nl
type
label
Generation of synthetic severe ...... sembly and vaccine production.
@en
Generation of synthetic severe ...... sembly and vaccine production.
@nl
prefLabel
Generation of synthetic severe ...... sembly and vaccine production.
@en
Generation of synthetic severe ...... sembly and vaccine production.
@nl
P2093
P2860
P1433
P1476
Generation of synthetic severe ...... sembly and vaccine production.
@en
P2093
Gary J Nabel
Wing-pui Kong
Zhi-yong Yang
P2860
P304
12557-12565
P356
10.1128/JVI.78.22.12557-12565.2004
P407
P577
2004-11-01T00:00:00Z